Search

everythinglearnresearchcommunity

for

Search:↓

Improving prostate and urinary health can enhance sexual function and mental well-being in older men.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

Finasteride is beneficial for BPH but requires careful monitoring due to cancer risks.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Zapoteca portoricensis extract may help protect against prostate issues and support liver and kidney health in rats.

Thermobalancing therapy is safe and effective for treating enlarged prostates.

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

Arachis hypogaea L. root extract reduces prostate enlargement and inflammation in mice.

Many patients with benign prostatic hyperplasia experience high anxiety and residual symptoms, needing better anxiety management.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Cuscuta reflexa extract may help treat benign prostatic hyperplasia by reducing inflammation and oxidative stress.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Nephrolepis biserrata may improve fertility and reduce prostate issues in males.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

A young dog with an enlarged prostate and cysts improved significantly after treatment and surgery.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Male pattern baldness may be an early sign of noncancerous prostate enlargement.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Urinary PSA could be an early marker for enlarged prostate.

Finasteride reduces prostate cancer risk but may increase high-grade cancer cases.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Physalis peruviana extract is more effective in treating benign prostatic hyperplasia in rats than finasteride and terazosine.

There is no link between hair loss and prostate enlargement.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.